Lippman Evan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$1.48M

Insider Activity of Lippman Evan

According to the SEC Form 4 filings, Lippman Evan, being in a position of

  1. EVP, Business Development at Teva Pharmaceutical Industries Limited,
    оver the last 12 months, has bought 0 shares, and sold 60258 shares for $2.16M,
    over all time since 2026-05-14, has bought 0 shares, and sold 60258 shares for $2.16M.

Biography of Lippman Evan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,162,6582100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Business Development
18,600
0.0016%
$36.57$680,291+7.65%
2026-05-14SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Business Development
41,658
0.0036%
$35.58$1.48M+2.35%
Total: 2
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.